Research summary, original research, 2017

Radiation-Induced DNA Damage in Operators Performing Endovascular Aortic Repair

El-Sayed T, Patel AS, Cho JS, Kelly JA, Ludwinski FE, Saha P, et al.. Circulation. 2017

Read the original paper

In plain language

In 15 UK vascular surgeons and interventional radiologists, markers of DNA damage in blood cells rose briefly after complex endovascular aortic repair and returned to baseline in 24 hours. The rise was absent when operators wore leg shielding. Long-term health significance is unknown.

At a glance

Type of study
Original research, Laboratory or biomarker study
Who was studied
Vascular surgeons, Interventional radiologists, Patients
Size
n = 15 operators
Where
United Kingdom
Summary based on
the full text

What it found

  • Both DNA damage markers rose significantly in operators' lymphocytes immediately after branched/fenestrated endovascular aneurysm repair (EVAR); only pATM rose after infrarenal EVAR.

    Key figures: P<0.0003 for both (BEVAR/fenestrated endovascular aneurysm repair (FEVAR)); pATM P<0.04 (IEVAR)

  • Wearing lower leg lead shielding abolished the γ-H2AX and pATM response after complex EVAR, with comparable dose-area product (DAP) and screening times.

    Key figures: 9 shielded vs 16 unshielded branched endovascular aneurysm repair (BEVAR)/FEVAR cases, P<0.05

  • Marker levels returned to baseline within 24 hours, and no change occurred after open (non-fluoroscopic) repair.

    Key figures: P<0.003 for both

  • Leg-level dosimeter readings were higher than chest readings, and about twice as high in complex versus standard EVAR.

    Key figures: ≈2-fold higher leg exposure; P<0.0001

  • Operators' blood irradiated in vitro at the same dose showed significantly different γ-H2AX responses, suggesting individual variation in susceptibility.

    Key figures: n=6, P<0.0001

Limits to keep in mind

Small single-centre sample (15 operators, 6 in the leg-shield and in vitro substudies) with non-randomized comparison; markers reflect an acute, transient cellular response with no established link to cancer risk or long-term outcomes.

How this summary was made

ORSIF prepared this summary with AI assistance from the full text of the paper. A program then checked that the passage supporting each finding appears word for word in that source. A person has not yet reviewed each summary, so read the original before relying on a number. ORSIF summarizes research and does not endorse any product or company. Report a problem with this summary.

Prepared November 3, 2026.